25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Q BioMed Inc
Buy, Hold or Sell?

Let's analyze Q BioMed Inc together

I guess you are interested in Q BioMed Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Q BioMed Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Q BioMed Inc

I send you an email if I find something interesting about Q BioMed Inc.

1. Quick Overview

1.1. Quick analysis of Q BioMed Inc (30 sec.)










1.2. What can you expect buying and holding a share of Q BioMed Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.03
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$-0.03
Expected worth in 1 year
$-0.03
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.03
Return On Investment
28,563.4%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Q BioMed Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.18 - $0.45
Total Value Per Share
$0.15 - $0.42

2.2. Growth of Q BioMed Inc (5 min.)




Is Q BioMed Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$4.6m-$4.6m$67.9k1.5%

How much money is Q BioMed Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$8.7m$6.6m326.3%
Net Profit Margin-721.7%-4,472.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Q BioMed Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Q BioMed Inc?

Welcome investor! Q BioMed Inc's management wants to use your money to grow the business. In return you get a share of Q BioMed Inc.

First you should know what it really means to hold a share of Q BioMed Inc. And how you can make/lose money.

Speculation

The Price per Share of Q BioMed Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Q BioMed Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Q BioMed Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.03. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Q BioMed Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.02-24,081.4%-0.02-24,081.4%-0.06-60,245.2%-0.06-63,594.3%-0.05-47,537.4%
Usd Book Value Change Per Share0.00468.2%0.00468.2%-0.02-24,879.4%-0.01-6,855.7%0.00-3,182.3%
Usd Dividend Per Share0.016,672.6%0.016,672.6%0.003,451.0%0.002,541.7%0.001,270.9%
Usd Total Gains Per Share0.017,140.8%0.017,140.8%-0.02-21,428.4%0.00-4,314.0%0.00-1,911.5%
Usd Price Per Share0.02-0.02-0.45-1.02-1.66-
Price to Earnings Ratio-0.66--0.66--7.50--14.48--66.06-
Price-to-Total Gains Ratio2.24-2.24--21.09--128.31--321.89-
Price to Book Ratio-0.50--0.50--14.00--577.00--331.26-
Price-to-Total Gains Ratio2.24-2.24--21.09--128.31--321.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.010.00
Gains per Quarter (10000000 shares)71,408.38-43,140.05
Gains per Year (10000000 shares)285,633.53-172,560.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126690418730285624101669-274229-172570
253380737460571258203339-548459-345130
380071156189856892305008-822688-517690
41067615749191142526406677-1096918-690250
51334519936491428160508346-1371147-862810
616014221123791713794610016-1645377-1035370
718683261311091999428711685-1919606-1207930
821352301498382285062813354-2193836-1380490
924021341685682570696915023-2468065-1553050
10266903718729828563301016693-2742295-1725610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%3.00.02.060.0%3.00.07.030.0%3.00.07.030.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Q BioMed Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%-0.025+5413%-0.007+1564%-0.003+780%
Book Value Per Share---0.032-0.0320%-0.032+1%-0.021-33%-0.012-62%
Current Ratio--0.0090.0090%0.084-89%1.308-99%6.963-100%
Debt To Asset Ratio--2.3132.3130%6.788-66%4.348-47%2.776-17%
Debt To Equity Ratio----0%-0%-0%0.145-100%
Dividend Per Share--0.0070.0070%0.003+93%0.003+163%0.001+425%
Eps---0.024-0.0240%-0.060+150%-0.064+164%-0.048+97%
Free Cash Flow Per Share--0.0130.0130%-0.030+322%-0.027+302%-0.021+254%
Free Cash Flow To Equity Per Share--0.0200.0200%0.001+1607%0.003+501%0.002+709%
Gross Profit Margin--1.0151.0150%1.000+1%1.003+1%1.001+1%
Intrinsic Value_10Y_max--0.454--------
Intrinsic Value_10Y_min--0.184--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.016--------
Intrinsic Value_3Y_max--0.022--------
Intrinsic Value_3Y_min---0.018--------
Intrinsic Value_5Y_max--0.097--------
Intrinsic Value_5Y_min--0.012--------
Market Cap14509.501-15900%2321520.1282321520.1280%65582943.616-96%148519250.189-98%240683599.270-99%
Net Profit Margin---7.217-7.2170%-44.722+520%-102.310+1318%-51.155+609%
Operating Margin---2.348-2.3480%-39.539+1584%-96.350+4004%-48.175+1952%
Operating Ratio--13.11713.1170%38.774-66%98.214-87%49.107-73%
Pb Ratio-0.003+99%-0.503-0.5030%-13.997+2684%-576.997+114663%-331.264+65787%
Pe Ratio-0.004+99%-0.664-0.6640%-7.503+1029%-14.478+2079%-66.062+9843%
Price Per Share0.000-15900%0.0160.0160%0.452-96%1.024-98%1.659-99%
Price To Free Cash Flow Ratio0.007-15900%1.1961.1960%-15.245+1375%-27.383+2390%-621.166+52046%
Price To Total Gains Ratio0.014-15900%2.2412.2410%-21.093+1041%-128.314+5827%-321.890+14466%
Quick Ratio--0.0080.0080%0.077-90%1.295-99%6.956-100%
Return On Assets---0.584-0.5840%-10.806+1751%-10.948+1776%-8.850+1416%
Return On Equity----0%-0%-0%-4.4160%
Total Gains Per Share--0.0070.0070%-0.021+400%-0.004+160%-0.002+127%
Usd Book Value---4617422.000-4617422.0000%-4685362.000+1%-3105866.800-33%-1743616.000-62%
Usd Book Value Change Per Share--0.0000.0000%-0.025+5413%-0.007+1564%-0.003+780%
Usd Book Value Per Share---0.032-0.0320%-0.032+1%-0.021-33%-0.012-62%
Usd Dividend Per Share--0.0070.0070%0.003+93%0.003+163%0.001+425%
Usd Eps---0.024-0.0240%-0.060+150%-0.064+164%-0.048+97%
Usd Free Cash Flow--1941404.0001941404.0000%-4302036.000+322%-3929944.200+302%-2690817.400+239%
Usd Free Cash Flow Per Share--0.0130.0130%-0.030+322%-0.027+302%-0.021+254%
Usd Free Cash Flow To Equity Per Share--0.0200.0200%0.001+1607%0.003+501%0.002+709%
Usd Market Cap14509.501-15900%2321520.1282321520.1280%65582943.616-96%148519250.189-98%240683599.270-99%
Usd Price Per Share0.000-15900%0.0160.0160%0.452-96%1.024-98%1.659-99%
Usd Profit---2052093.000-2052093.0000%-8747472.000+326%-9119772.400+344%-6843720.700+233%
Usd Revenue--284352.000284352.0000%195597.000+45%101989.800+179%50994.900+458%
Usd Total Gains Per Share--0.0070.0070%-0.021+400%-0.004+160%-0.002+127%
 EOD+2 -6MRQTTM+0 -0YOY+26 -85Y+23 -1110Y+24 -11

3.3 Fundamental Score

Let's check the fundamental score of Q BioMed Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.004
Price to Book Ratio (EOD)Between0-1-0.003
Net Profit Margin (MRQ)Greater than0-7.217
Operating Margin (MRQ)Greater than0-2.348
Quick Ratio (MRQ)Greater than10.008
Current Ratio (MRQ)Greater than10.009
Debt to Asset Ratio (MRQ)Less than12.313
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.584
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Q BioMed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.399
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Q BioMed Inc

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-11-16 16:42:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Q BioMed Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -721.7% means that $-7.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Q BioMed Inc:

  • The MRQ is -721.7%. The company is making a huge loss. -2
  • The TTM is -721.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-721.7%TTM-721.7%0.0%
TTM-721.7%YOY-4,472.2%+3,750.5%
TTM-721.7%5Y-10,231.0%+9,509.4%
5Y-10,231.0%10Y-5,115.5%-5,115.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-721.7%-120.2%-601.5%
TTM-721.7%-210.7%-511.0%
YOY-4,472.2%-219.8%-4,252.4%
5Y-10,231.0%-348.0%-9,883.0%
10Y-5,115.5%-473.2%-4,642.3%
4.3.1.2. Return on Assets

Shows how efficient Q BioMed Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • -58.4% Return on Assets means that Q BioMed Inc generated $-0.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Q BioMed Inc:

  • The MRQ is -58.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.4%TTM-58.4%0.0%
TTM-58.4%YOY-1,080.6%+1,022.3%
TTM-58.4%5Y-1,094.8%+1,036.4%
5Y-1,094.8%10Y-885.0%-209.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.4%-11.0%-47.4%
TTM-58.4%-11.8%-46.6%
YOY-1,080.6%-11.3%-1,069.3%
5Y-1,094.8%-12.6%-1,082.2%
10Y-885.0%-14.3%-870.7%
4.3.1.3. Return on Equity

Shows how efficient Q BioMed Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Q BioMed Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Q BioMed Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-441.6%+441.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.8%+15.8%
YOY--13.9%+13.9%
5Y--18.5%+18.5%
10Y-441.6%-19.2%-422.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Q BioMed Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Q BioMed Inc is operating .

  • Measures how much profit Q BioMed Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • An Operating Margin of -234.8% means the company generated $-2.35  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Q BioMed Inc:

  • The MRQ is -234.8%. The company is operating very inefficient. -2
  • The TTM is -234.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-234.8%TTM-234.8%0.0%
TTM-234.8%YOY-3,953.9%+3,719.1%
TTM-234.8%5Y-9,635.0%+9,400.3%
5Y-9,635.0%10Y-4,817.5%-4,817.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-234.8%-267.8%+33.0%
TTM-234.8%-313.4%+78.6%
YOY-3,953.9%-224.0%-3,729.9%
5Y-9,635.0%-385.5%-9,249.5%
10Y-4,817.5%-498.7%-4,318.8%
4.3.2.2. Operating Ratio

Measures how efficient Q BioMed Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 13.12 means that the operating costs are $13.12 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Q BioMed Inc:

  • The MRQ is 13.117. The company is inefficient in keeping operating costs low. -1
  • The TTM is 13.117. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ13.117TTM13.1170.000
TTM13.117YOY38.774-25.657
TTM13.1175Y98.214-85.097
5Y98.21410Y49.107+49.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.1172.631+10.486
TTM13.1173.412+9.705
YOY38.7743.299+35.475
5Y98.2144.788+93.426
10Y49.1076.538+42.569
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Q BioMed Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Q BioMed Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.01 means the company has $0.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Q BioMed Inc:

  • The MRQ is 0.009. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.009. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.009TTM0.0090.000
TTM0.009YOY0.084-0.075
TTM0.0095Y1.308-1.299
5Y1.30810Y6.963-5.655
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0093.690-3.681
TTM0.0093.875-3.866
YOY0.0844.684-4.600
5Y1.3085.946-4.638
10Y6.9636.274+0.689
4.4.3.2. Quick Ratio

Measures if Q BioMed Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Q BioMed Inc:

  • The MRQ is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.008TTM0.0080.000
TTM0.008YOY0.077-0.070
TTM0.0085Y1.295-1.287
5Y1.29510Y6.956-5.661
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0083.122-3.114
TTM0.0083.451-3.443
YOY0.0774.498-4.421
5Y1.2955.922-4.627
10Y6.9566.414+0.542
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Q BioMed Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Q BioMed Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Q BioMed Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.31 means that Q BioMed Inc assets are financed with 231.3% credit (debt) and the remaining percentage (100% - 231.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Q BioMed Inc:

  • The MRQ is 2.313. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.313. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.313TTM2.3130.000
TTM2.313YOY6.788-4.475
TTM2.3135Y4.348-2.034
5Y4.34810Y2.776+1.572
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3130.353+1.960
TTM2.3130.350+1.963
YOY6.7880.311+6.477
5Y4.3480.367+3.981
10Y2.7760.382+2.394
4.5.4.2. Debt to Equity Ratio

Measures if Q BioMed Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Q BioMed Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Q BioMed Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.145-0.145
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.435-0.435
YOY-0.378-0.378
5Y-0.451-0.451
10Y0.1450.493-0.348
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Q BioMed Inc generates.

  • Above 15 is considered overpriced but always compare Q BioMed Inc to the Biotechnology industry mean.
  • A PE ratio of -0.66 means the investor is paying $-0.66 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Q BioMed Inc:

  • The EOD is -0.004. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.664. Based on the earnings, the company is expensive. -2
  • The TTM is -0.664. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.004MRQ-0.664+0.660
MRQ-0.664TTM-0.6640.000
TTM-0.664YOY-7.503+6.838
TTM-0.6645Y-14.478+13.814
5Y-14.47810Y-66.062+51.583
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.004-2.126+2.122
MRQ-0.664-2.454+1.790
TTM-0.664-3.147+2.483
YOY-7.503-3.335-4.168
5Y-14.478-6.070-8.408
10Y-66.062-6.597-59.465
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Q BioMed Inc:

  • The EOD is 0.007. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.196. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.196. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.007MRQ1.196-1.188
MRQ1.196TTM1.1960.000
TTM1.196YOY-15.245+16.440
TTM1.1965Y-27.383+28.578
5Y-27.38310Y-621.166+593.783
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.007-2.981+2.988
MRQ1.196-3.363+4.559
TTM1.196-3.667+4.863
YOY-15.245-4.535-10.710
5Y-27.383-8.343-19.040
10Y-621.166-9.276-611.890
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Q BioMed Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.50 means the investor is paying $-0.50 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Q BioMed Inc:

  • The EOD is -0.003. Based on the equity, the company is expensive. -2
  • The MRQ is -0.503. Based on the equity, the company is expensive. -2
  • The TTM is -0.503. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.003MRQ-0.503+0.500
MRQ-0.503TTM-0.5030.000
TTM-0.503YOY-13.997+13.495
TTM-0.5035Y-576.997+576.494
5Y-576.99710Y-331.264-245.733
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0031.863-1.866
MRQ-0.5032.028-2.531
TTM-0.5032.339-2.842
YOY-13.9972.391-16.388
5Y-576.9973.666-580.663
10Y-331.2644.360-335.624
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-11-302019-11-302020-11-302021-11-302022-11-30
Income Tax Expense  2511,2091,460-1,164296211507-1,843-1,336
Total Other Income Expense Net -89-2,171-2,2601,913-347-505-8522,2461,394



6.2. Latest Balance Sheet

Balance Sheet of 2022-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,516
Total Liabilities8,133
Total Stockholder Equity-4,617
 As reported
Total Liabilities 8,133
Total Stockholder Equity+ -4,617
Total Assets = 3,516

Assets

Total Assets3,516
Total Current Assets72
Long-term Assets3,443
Total Current Assets
Cash And Cash Equivalents 50
Net Receivables 12
Other Current Assets 11
Total Current Assets  (as reported)72
Total Current Assets  (calculated)72
+/-0
Long-term Assets
Long Term Investments 3,143
Intangible Assets 300
Long-term Assets  (as reported)3,443
Long-term Assets  (calculated)3,443
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,133
Long-term Liabilities0
Total Stockholder Equity-4,617
Total Current Liabilities
Short-term Debt 4,110
Short Long Term Debt 4,110
Accounts payable 2,132
Other Current Liabilities 1,891
Total Current Liabilities  (as reported)8,133
Total Current Liabilities  (calculated)12,243
+/- 4,110
Long-term Liabilities
Other Liabilities 0
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock84
Retained Earnings -66,096
Other Stockholders Equity 56,309
Total Stockholder Equity (as reported)-4,617
Total Stockholder Equity (calculated)-9,703
+/- 5,086
Other
Capital Stock5,170
Cash and Short Term Investments 50
Common Stock Shares Outstanding 44,757
Liabilities and Stockholders Equity 3,516
Net Debt 4,060
Net Invested Capital -5,593
Net Tangible Assets -10,003
Net Working Capital -8,061
Short Long Term Debt Total 4,110



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-11-302021-11-302020-11-302019-11-302018-11-302017-11-302016-11-302015-11-302014-11-302013-11-30
> Total Assets 
25
13
131
1,469
827
3,197
640
623
809
3,516
3,5168096236403,1978271,4691311325
   > Total Current Assets 
25
13
131
1,469
827
2,697
190
223
459
72
724592231902,6978271,4691311325
       Cash And Cash Equivalents 
25
13
131
1,469
825
2,684
173
177
344
50
503441771732,6848251,4691311325
       Net Receivables 
0
0
0
0
0
0
0
0
80
12
128000000000
       Other Current Assets 
0
0
0
0
3
13
35
93
48
11
114893351330000
   > Long-term Assets 
0
0
0
0
0
500
450
400
350
3,443
3,44335040045050000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
3,143
3,143000000000
       Intangible Assets 
0
0
0
0
0
500
450
400
350
300
30035040045050000000
> Total Liabilities 
1
1
387
3,512
471
3,303
5,686
1,699
5,495
8,133
8,1335,4951,6995,6863,3034713,51238711
   > Total Current Liabilities 
1
1
387
3,280
471
429
5,238
1,699
5,495
8,133
8,1335,4951,6995,2384294713,28038711
       Short-term Debt 
0
0
296
2,495
0
0
3,243
92
3,053
4,110
4,1103,053923,243002,49529600
       Short Long Term Debt 
0
0
296
2,495
0
0
3,243
92
3,053
4,110
4,1103,053923,243002,49529600
       Accounts payable 
1
1
59
498
464
392
652
722
1,345
2,132
2,1321,3457226523924644985911
       Other Current Liabilities 
0
0
91
168
8
37
1,343
885
1,096
1,891
1,8911,0968851,3433781689100
   > Long-term Liabilities 
0
0
0
232
0
2,873
447
0
0
0
0004472,8730232000
> Total Stockholder Equity
25
11
-256
-2,043
356
-106
-5,045
-1,075
-4,685
-4,617
-4,617-4,685-1,075-5,045-106356-2,043-2561125
   Common Stock
2
3
9
9
12
14
20
24
29
84
8429242014129932
   Retained Earnings -66,096-64,127-55,886-42,394-32,114-22,843-8,302-1,130-39-1
   Capital Surplus 
0
0
0
0
0
0
0
47,656
0
0
0047,6560000000
   Treasury Stock0000000000
   Other Stockholders Equity 
23
47
866
6,249
23,187
31,994
37,329
47,656
53,336
56,309
56,30953,33647,65637,32931,99423,1876,2498664723



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2022-11-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue284
Cost of Revenue-293
Gross Profit-9-9
 
Operating Income (+$)
Gross Profit-9
Operating Expense-3,437
Operating Income-3,446-3,446
 
Operating Expense (+$)
Research Development125
Selling General Administrative3,281
Selling And Marketing Expenses30
Operating Expense3,4373,437
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,384
Other Finance Cost-0
Net Interest Income-1,384
 
Pretax Income (+$)
Operating Income-3,446
Net Interest Income-1,384
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,052-4,839
EBIT - interestExpense = -2,052
-3,388
-668
Interest Expense1,384
Earnings Before Interest and Taxes (EBIT)-668-668
Earnings Before Interest and Taxes (EBITDA)-618
 
After tax Income (+$)
Income Before Tax-2,052
Tax Provision-0
Net Income From Continuing Ops-2,052-2,052
Net Income-2,052
Net Income Applicable To Common Shares-3,494
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,730
Total Other Income/Expenses Net1,3941,384
 

Technical Analysis of Q BioMed Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Q BioMed Inc. The general trend of Q BioMed Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Q BioMed Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Q BioMed Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Q BioMed Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Q BioMed Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Q BioMed Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Q BioMed Inc. The current macd is -0.000076.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Q BioMed Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Q BioMed Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Q BioMed Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Q BioMed Inc Daily Moving Average Convergence/Divergence (MACD) ChartQ BioMed Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Q BioMed Inc. The current adx is 85.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Q BioMed Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Q BioMed Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Q BioMed Inc. The current sar is 0.00038373.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Q BioMed Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Q BioMed Inc. The current rsi is 0.3991778. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Q BioMed Inc Daily Relative Strength Index (RSI) ChartQ BioMed Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Q BioMed Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Q BioMed Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Q BioMed Inc Daily Stochastic Oscillator ChartQ BioMed Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Q BioMed Inc. The current cci is -35.0877193.

Q BioMed Inc Daily Commodity Channel Index (CCI) ChartQ BioMed Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Q BioMed Inc. The current cmo is -99.97567114.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Q BioMed Inc Daily Chande Momentum Oscillator (CMO) ChartQ BioMed Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Q BioMed Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Q BioMed Inc Daily Williams %R ChartQ BioMed Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Q BioMed Inc.

Q BioMed Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Q BioMed Inc. The current atr is 0.00001.

Q BioMed Inc Daily Average True Range (ATR) ChartQ BioMed Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Q BioMed Inc. The current obv is 35,760,018.

Q BioMed Inc Daily On-Balance Volume (OBV) ChartQ BioMed Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Q BioMed Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Q BioMed Inc Daily Money Flow Index (MFI) ChartQ BioMed Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Q BioMed Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Q BioMed Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Q BioMed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.399
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Q BioMed Inc with someone you think should read this too:
  • Are you bullish or bearish on Q BioMed Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Q BioMed Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Q BioMed Inc

I send you an email if I find something interesting about Q BioMed Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Q BioMed Inc.

Receive notifications about Q BioMed Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.